235 related articles for article (PubMed ID: 32648951)
1. Dual-trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study.
Zhou L; Bhattacharjee S; Kwoh CK; Tighe PJ; Reisfield GM; Malone DC; Slack M; Wilson DL; Chang CY; Lo-Ciganic WH
Addiction; 2021 Apr; 116(4):819-830. PubMed ID: 32648951
[TBL] [Abstract][Full Text] [Related]
2. Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries.
Zhou L; Bhattacharjee S; Kwoh CK; Malone DC; Tighe PJ; Reisfield GM; Slack M; Wilson DL; Lo-Ciganic WH
Value Health; 2021 Feb; 24(2):196-205. PubMed ID: 33518026
[TBL] [Abstract][Full Text] [Related]
3. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models.
Lo-Ciganic WH; Hincapie-Castillo J; Wang T; Ge Y; Jones BL; Huang JL; Chang CY; Wilson DL; Lee JK; Reisfield GM; Kwoh CK; Delcher C; Nguyen KA; Zhou L; Shorr RI; Guo J; Marcum ZA; Harle CA; Park H; Winterstein A; Yang S; Huang PL; Adkins L; Gellad WF
Addiction; 2022 Jul; 117(7):1982-1997. PubMed ID: 35224799
[TBL] [Abstract][Full Text] [Related]
4. Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study.
Wei YJ; Chen C; Lewis MO; Schmidt SO; Winterstein AG
PLoS Med; 2022 Mar; 19(3):e1003947. PubMed ID: 35290389
[TBL] [Abstract][Full Text] [Related]
5. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
Chang CY; Jones BL; Hincapie-Castillo JM; Park H; Heldermon CD; Diaby V; Wilson DL; Lo-Ciganic WH
Breast Cancer Res Treat; 2024 Apr; 204(3):561-577. PubMed ID: 38191684
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study.
Chen C; Winterstein AG; Lo-Ciganic WH; Tighe PJ; Wei YJ
PLoS Med; 2022 Mar; 19(3):e1003921. PubMed ID: 35231025
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.
Lo-Ciganic WH; Huang JL; Zhang HH; Weiss JC; Wu Y; Kwoh CK; Donohue JM; Cochran G; Gordon AJ; Malone DC; Kuza CC; Gellad WF
JAMA Netw Open; 2019 Mar; 2(3):e190968. PubMed ID: 30901048
[TBL] [Abstract][Full Text] [Related]
8. Changes in predicted opioid overdose risk over time in a state Medicaid program: a group-based trajectory modeling analysis.
Guo J; Gellad WF; Yang Q; Weiss JC; Donohue JM; Cochran G; Gordon AJ; Malone DC; Kwoh CK; Kuza CC; Wilson DL; Lo-Ciganic WH
Addiction; 2022 Aug; 117(8):2254-2263. PubMed ID: 35315173
[TBL] [Abstract][Full Text] [Related]
9. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States.
Bykov K; Bateman BT; Franklin JM; Vine SM; Patorno E
JAMA Netw Open; 2020 Dec; 3(12):e2031647. PubMed ID: 33372975
[TBL] [Abstract][Full Text] [Related]
10. Opioid and Benzodiazepine Substitutes: Impact on Drug Overdose Mortality in Medicare Population.
Kuo YF; Liaw V; Yu X; Raji MA
Am J Med; 2022 Jul; 135(7):e194-e206. PubMed ID: 35341773
[TBL] [Abstract][Full Text] [Related]
11. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries.
Hernandez I; He M; Brooks MM; Zhang Y
JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080
[TBL] [Abstract][Full Text] [Related]
12. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
13. Association of co-prescribing of opioid and benzodiazepine substitutes with incident falls and fractures among older adults: a cohort study.
Shah R; Raji MA; Westra J; Kuo YF
BMJ Open; 2021 Dec; 11(12):e052057. PubMed ID: 35476819
[TBL] [Abstract][Full Text] [Related]
14. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
[TBL] [Abstract][Full Text] [Related]
15. Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study.
Maust DT; Bohnert ASB; Strominger J; Goldstick JE
BMC Pharmacol Toxicol; 2023 May; 24(1):34. PubMed ID: 37208726
[TBL] [Abstract][Full Text] [Related]
16. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries.
Kuo YF; Baillargeon J; Raji MA
J Subst Abuse Treat; 2021 May; 124():108282. PubMed ID: 33771281
[TBL] [Abstract][Full Text] [Related]
17. Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults.
Bongiovanni T; Gan S; Finlayson E; Ross JS; Harrison JD; Boscardin WJ; Steinman MA
JAMA Netw Open; 2023 Jun; 6(6):e2318626. PubMed ID: 37326989
[TBL] [Abstract][Full Text] [Related]
18. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
19. Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study.
Henry SG; Fang SY; Crawford AJ; Wintemute GJ; Tseregounis IE; Gasper JJ; Shev A; Cartus AR; Marshall BDL; Tancredi DJ; Cerdá M; Stewart SL
J Gen Intern Med; 2024 Feb; 39(3):393-402. PubMed ID: 37794260
[TBL] [Abstract][Full Text] [Related]
20. Co-prescribing of Central Nervous System-Active Medications for COPD Patients: Impact on Emergency Room Visits and Hospitalization.
Sood A; Kuo YF; Westra J; Sharma G; Raji MA
Ann Pharmacother; 2023 Apr; 57(4):382-396. PubMed ID: 35942598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
